Heritable Thrombophilia-Hypofibrinolysis and Osteonecrosis of the Femoral Head

详细信息    查看全文

• 作者：Charles J. Glueck MD (1)
  Richard A. Freiberg MD (2)
  Ping Wang PhD (1)
  
• 刊名：Clinical Orthopaedics and Related Research?
• 出版年：2008
• 出版时间：May 2008
• 年：2008
• 卷：466
• 期：5
• 页码：1034-1040
• 全文大小：181KB
• 参考文献：1. Aksoy MC, Aksoy DY, Haznedaroglu IC, Sayinalp N, Kirazli S, Alpaslan M. Enhanced tissue factor pathway inhibitor response as a defense mechanism against ongoing local microvascular events of Legg-Calve-Perthes disease. / Pediatr Hematol Oncol. 2005;22:391-99. CrossRef
  2. Asano T, Takahashi KA, Fujioka M, Inoue S, Okamoto M, Sugioka N, Nishino H, Tanaka T, Hirota Y, Kubo T. ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation. / Pharmacogenetics. 2003;13:675-82. CrossRef
  3. Assouline-Dayan Y, Chang C, Greenspan A, Shoenfeld Y, Gershwin ME. Pathogenesis and natural history of osteonecrosis. / Semin Arthritis Rheum. 2002;32:94-24.
  4. Balasa VV, Gruppo RA, Glueck CJ, Stroop D, Becker A, Pillow A, Wang P. The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults. / Thromb Haemost. 1999;81:739-44.
  5. Balasa VV, Gruppo RA, Glueck CJ, Wang P, Roy DR, Wall EJ, Mehlman CT, Crawford AH. Legg-Calve-Perthes disease and thrombophilia. / J Bone Joint Surg Am. 2004;86:2642-647.
  6. Bank I, Libourel EJ, Middeldorp S, Hamulyak K, van Pampus EC, Koopman MM, Prins MH, van der Meer J, Buller HR. Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis. / J Thromb Haemost. 2005;3:79-4. j.1538-7836.2004.01033.x">CrossRef
  7. Berger CE, Kluger R, Urban M, Kowalski J, Haas OA, Engel A. Elevated levels of lipoprotein(a) in familial bone marrow edema syndrome of the hip. / Clin Orthop Relat Res. 2000;377:126-31. CrossRef
  8. Berger CE, Kroner A, Stiegler H, Erdel M, Haas OA, Engel A. Hypofibrinolysis, lipoprotein(a), and plasminogen activator inhibitor. / Clin Orthop Relat Res. 2002;397:342-49. CrossRef
  9. Bjorkman A, Burtscher IM, Svensson PJ, Hillarp A, Besjakov J, Benoni G. Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee. / Arch Orthop Trauma Surg. 2005;125:51-5. CrossRef
  10. Bjorkman A, Svensson PJ, Hillarp A, Burtscher IM, Runow A, Benoni G. Factor V Leiden and prothrombin gene mutation: risk factors for osteonecrosis of the femoral head in adults. / Clin Orthop Relat Res. 2004;425:168-72. CrossRef
  11. Blanche P, Si-Larbi AG, Jouve P. Femoral head necrosis and hyperhomocysteinemia. / J Rheumatol. 2001;28:1469.
  12. Boss JH, Misselevich I. Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals. / Vet Pathol. 2003;40:345-54. CrossRef
  13. Boss JH, Misselevich I, Bejar J, Norman D, Zinman C, Reis DN. Experimentally gained insight-based proposal apropos the treatment of osteonecrosis of the femoral head. / Med Hypotheses. 2004;62:958-65. j.mehy.2003.12.036">CrossRef
  14. Celik A, Tekis D, Saglam F, Tunali S, Kabakci N, Ozaksoy D, Manisali M, Ozcan MA, Meral M, Gulay H, Camsari T. Association of corticosteroids and Factor V, prothrombin, and MTHFR gene mutations with avascular osteonecrosis in renal allograft recipients. / Transplant Proc. 2006;38:512-16. j.transproceed.2005.12.062">CrossRef
  15. Chao YC, Wang SJ, Chu HC, Chang WK, Hsieh TY. Investigation of alcohol metabolizing enzyme genes in Chinese alcoholics with avascular necrosis of hip joint, pancreatitis and cirrhosis of the liver. / Alcohol Alcohol. 2003;38:431-36.
  16. Chen WM, Liu YF, Lin MW, Chen IC, Lin PY, Lin GL, Jou YS, Lin YT, Fann CS, Wu JY, Hsiao KJ, Tsai SF. Autosomal dominant avascular necrosis of femoral head in two Taiwanese pedigrees and linkage to chromosome 12q13. / Am J Hum Genet. 2004;75:310-17. CrossRef
  17. Coca M, Cucuianu M, Hancu N. Effect of abdominal obesity on prothrombotic tendency in type 2 diabetes. Behavior of clotting Factors VII and VIII, fibrinogen and von Willebrand factor. / Rom J Intern Med. 2005;43:115-26.
  18. Coogan PG, Urbaniak JR. Multicenter experience with free vascularized fibular grafts for osteonecrosis of the femoral head. In: Urbaniak JR, Jones JP Jr, eds. / Osteonecrosis: Etiology, Diagnosis, and Treatment. Rosemont, IL: American Academy of Orthopedic Surgeons; 1997:327-52.
  19. Eldridge J, Dilley A, Austin H, El-Jamil M, Wolstein L, Doris J, Hooper WC, Meehan PL, Evatt B. The role of protein C, protein S, and resistance to activated protein C in Legg-Perthes disease. / Pediatrics. 2001;107:1329-334. CrossRef
  20. Ficat P. Cortisone associated necrosis of bone. In: Hungerford D, ed. / Ischemia and Necrosis of Bone. Baltimore, MD: Williams & Wilkins; 1980:171-76.
  21. Garino JP, Steinberg ME. Total hip arthroplasty in patients with avascular necrosis of the femoral head: a 2- to 10-year follow-up. / Clin Orthop Relat Res. 1997;334:108-15. CrossRef
  22. Glueck CJ, Brandt G, Gruppo R, Crawford A, Roy D, Tracy T, Stroop D, Wang P, Becker A. Resistance to activated protein C and Legg-Perthes disease. / Clin Orthop Relat Res. 1997;338:139-52. CrossRef
  23. Glueck CJ, Crawford A, Roy D, Freiberg R, Glueck H, Stroop D. Association of antithrombotic factor deficiencies and hypofibrinolysis with Legg-Perthes disease. / J Bone Joint Surg Am. 1996;78:3-3.
  24. Glueck CJ, Fontaine RN, Gruppo R, Stroop D, Sieve-Smith L, Tracy T, Wang P. The plasminogen activator inhibitor-1 gene, hypofibrinolysis, and osteonecrosis. / Clin Orthop Relat Res. 1999;366:133-46. CrossRef
  25. Glueck CJ, Freiberg R, Glueck HI, Tracy T, Stroop D, Wang Y. Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol. / Am J Hematol. 1995;48:213-20. jh.2830480402">CrossRef
  26. Glueck CJ, Freiberg R, Oghene J, Fontaine RN, Wang P. Association between the T-786C eNOS polymorphism and idiopathic osteonecrosis of the head of the femur. / J Bone Joint Surg Am. 2007;89:1-6. CrossRef
  27. Glueck CJ, Freiberg R, Tracy T, Stroop D, Wang P. Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis. / Clin Orthop Relat Res. 1997;334:43-6. CrossRef
  28. Glueck CJ, Freiberg RA, Crawford A, Gruppo R, Roy D, Tracy T, Sieve-Smith L, Wang P. Secondhand smoke, hypofibrinolysis, and Legg-Perthes disease. / Clin Orthop Relat Res. 1998;352:159-67. CrossRef
  29. Glueck CJ, Freiberg RA, Fontaine RN, Sieve-Smith L, Wang P. Anticoagulant therapy for osteonecrosis associated with heritable hypofibrinolysis and thrombophilia. / Exp Opin Investig Drugs. 2001;10:1309-316. CrossRef
  30. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. / Clin Orthop Relat Res. 2001;386:19-3. CrossRef
  31. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. / Clin Orthop Relat Res. 2005;435:164-70. CrossRef
  32. Glueck CJ, Freiberg RA, Wang P. Role of thrombosis in osteonecrosis. / Curr Hematol Rep. 2003;2:417-22.
  33. Glueck CJ, Glueck HI, Greenfield D, Freiberg R, Kahn A, Hamer T, Stroop D, Tracy T. Protein C and S deficiency, thrombophilia, and hypofibrinolysis: pathophysiologic causes of Legg-Perthes disease. / Pediatr Res. 1994;35:383-88.
  34. Glueck CJ, Glueck HI, Mieczkowski L, Tracy T, Speirs J, Stroop D. Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis? / Thromb Haemost. 1993;69:460-65.
  35. Glueck CJ, Iyengar S, Goldenberg N, Smith LS, Wang P. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome. / J Lab Clin Med. 2003;142:35-5. CrossRef
  36. Glueck CJ, McMahon RE, Bouquot JE, Triplett D. Exogenous estrogen may exacerbate thrombophilia, impair bone healing and contribute to development of chronic facial pain. / Cranio. 1998;16:143-53.
  37. Glueck CJ, McMahon RE, Bouquot JE, Triplett D, Gruppo R, Wang P. Heterozygosity for the Leiden mutation of the Factor V gene, a common pathoetiology for osteonecrosis of the jaw, with thrombophilia augmented by exogenous estrogens. / J Lab Clin Med. 1997;130:540-43. CrossRef
  38. Glueck CJ, Munjal J, Aregawi D, Agloria M, Winiarska M, Khalil Q, Wang P. Thrombophilia-hypofibrinolysis and atherothrombotic cardiovascular disease <age 45. / Transl Res. 2007;150:93-00. j.trsl.2007.03.005">CrossRef
  39. Glueck CJ, Phillips HG, Cameron D, Wang P. Estrogen replacement in a protein S deficient patient leads to diarrhea, hyperglucagonemia, and osteonecrosis. / JOP. 2001;2:323-29.
  40. Gomes MP, Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. / Arch Intern Med. 2004;164:1965-976. CrossRef
  41. Gruppo R, Glueck CJ, Wall E, Roy D, Wang P. Legg-Perthes disease in three siblings, two heterozygous and one homozygous for the Factor V Leiden mutation. / J Pediatr. 1998;132:885-88. CrossRef
  42. Hofmann S, Mazieres B. Osteonecrosis: natural course and conservative therapy [in German]. / Orthopade. 2000;29:403-10.
  43. Jones JP. Risk factors potentially activating intravascular coagulation and causing nontraumatic osteonecrosis. In: Urbaniak JR, Jones JP Jr, eds. / Osteonecrosis: Etiology, Diagnosis, and Treatment. Rosemont, IL: American Academy of Orthopedic Surgeons; 1997:89-7.
  44. Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ. Procoagulants and osteonecrosis. / J Rheumatol. 2003;30:783.
  45. Kamphuisen PW, Eikenboom JC, Vos HL, Pablo R, Sturk A, Bertina RM, Rosendaal FR. Increased levels of Factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions. / Thromb Haemost. 1999;81:680-83.
  46. Koo KH, Kim R, Cho SH, Song HR, Lee G, Ko GH. Angiography, scintigraphy, intraosseous pressure, and histologic findings in high-risk osteonecrotic femoral heads with negative magnetic resonance images. / Clin Orthop Relat Res. 1994;308:127-38.
  47. Koo KH, Kim R, Ko GH, Song HR, Jeong ST, Cho SH. Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression. / J Bone Joint Surg Br. 1995;77:870-74.
  48. Koo KH, Lee JS, Lee YJ, Kim KJ, Yoo JJ, Kim HJ. Endothelial nitric oxide synthase gene polymorphisms in patients with nontraumatic femoral head osteonecrosis. / J Orthop Res. 2006;24:1722-728. jor.20164">CrossRef
  49. Korompilias AV, Gilkeson GS, Ortel TL, Seaber AV, Urbaniak JR. Anticardiolipin antibodies and osteonecrosis of the femoral head. / Clin Orthop Relat Res. 1997;345:174-80. CrossRef
  50. Korompilias AV, Ortel TL, Urbaniak JR. Coagulation abnormalities in patients with hip osteonecrosis. / Orthop Clin North Am. 2004;35:265-71, vii. j.ocl.2004.02.004">CrossRef
  51. Kubo T, Tsuji H, Yamamoto T, Nakahara H, Nakagawa M, Hirasawa Y. Antithrombin III deficiency in a patient with multifocal osteonecrosis. / Clin Orthop Relat Res. 2000;378:306-11. CrossRef
  52. Laroche M. Intraosseous circulation from physiology to disease. / Joint Bone Spine. 2002;69:262-69. CrossRef
  53. Lavigne G, Mercier E, Quere I, Dauzat M, Gris JC. Thrombophilic families with inheritably associated high levels of coagulation Factors VIII, IX and XI. / J Thromb Haemost. 2003;1:2134-139. j.1538-7836.2003.00410.x">CrossRef
  54. Legnani C, Cini M, Cosmi B, Poggi M, Boggian O, Palareti G. Risk of deep vein thrombosis: interaction between oral contraceptives and high Factor VIII levels. / Haematologica. 2004;89:1347-351.
  55. Li YZ, Yue T. Intraosseous pressure measurement and bone marrow venography in idiopathic necrosis of femoral head [in Chinese]. / Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1989;11:338-43.
  56. Lieberman JR. Core decompression for osteonecrosis of the hip. / Clin Orthop Relat Res. 2004;418:29-3. CrossRef
  57. Liu SL, Ho TC. The role of venous hypertension in the pathogenesis of Legg-Perthes disease. A clinical and experimental study. / J Bone Joint Surg Am. 1991;73:194-00.
  58. McKee MD, Waddell JP, Kudo PA, Schemitsch EH, Richards RR. Osteonecrosis of the femoral head in men following short-course corticosteroid therapy: a report of 15 cases. / CMAJ. 2001;164:205-06.
  59. Mont MA, Glueck CJ, Pacheco IH, Wang P, Hungerford DS, Petri M. Risk factors for osteonecrosis in systemic lupus erythematosus. / J Rheumatol. 1997;24:654-62.
  60. Mont MA, Jones LC, Rajadhyaksha AD, Shuler MS, Hungerford DS, Sieve-Smith L, Wang P, Cordista AG, Glueck CJ. Risk factors for pulmonary emboli after total hip or knee arthroplasty. / Clin Orthop Relat Res. 2004;422:154-63. CrossRef
  61. Montella BJ, Nunley JA, Urbaniak JR. Osteonecrosis of the femoral head associated with pregnancy. A preliminary report. / J Bone Joint Surg Am. 1999;81:790-98. CrossRef
  62. Nilsson IM, Krook H, Sternby NH, Soderberg E, Soderstrom N. Severe thrombotic disease in a young man with bone marrow and skeletal changes and with a high content of an inhibitor in the fibrinolytic system. / Acta Med Scand. 1961;169:323-37. j.0954-6820.1961.tb07838.x">CrossRef
  63. Norman D, Miller Y, Sabo E, Misselevich I, Peskin B, Zinman C, Levin D, Reis DN, Boss JH. The effects of enoxaparin on the reparative processes in experimental osteonecrosis of the femoral head of the rat. / APMIS. 2002;110:221-28. j.1600-0463.2002.100304.x">CrossRef
  64. Petersen NH, Schmied AB, Zeller JA, Plendl H, Deuschl G, Zunker P. Lp(a) lipoprotein and plasminogen activity in patients with different etiology of ischemic stroke. / Cerebrovasc Dis. 2007;23:188-93. CrossRef
  65. Pierre-Jacques H, Glueck CJ, Mont MA, Hungerford DS. Familial heterozygous protein-S deficiency in a patient who had multifocal osteonecrosis. A case report. / J Bone Joint Surg Am. 1997;79:1079-084.
  66. Posan E, Szepesi K, Gaspar L, Csernatony Z, Harsfalvi J, Ajzner E, Toth A, Udvardy M. Thrombotic and fibrinolytic alterations in the aseptic necrosis of femoral head. / Blood Coagul Fibrinolysis. 2003;14:243-48. CrossRef
  67. Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. / Lancet. 1992;340:873-76.
  68. Salvati EA, Della Valle AG, Westrich GH, Rana AJ, Specht L, Weksler BB, Wang P, Glueck CJ. The John Charnley Award: heritable thrombophilia and development of thromboembolic disease after total hip arthroplasty. / Clin Orthop Relat Res. 2005;441:40-5. CrossRef
  69. Schambeck CM, Hinney K, Haubitz I, Mansouri Taleghani B, Wahler D, Keller F. Familial clustering of high Factor VIII levels in patients with venous thromboembolism. / Arterioscler Thromb Vasc Biol. 2001;21:289-92.
  70. Stulberg BN, Davis AW, Bauer TW, Levine M, Easley K. Osteonecrosis of the femoral head. A prospective randomized treatment protocol. / Clin Orthop Relat Res. 1991;268:140-51.
  71. Sun W, Li ZR, Shi ZC, Zhang NF, Zhang YC. Changes in coagulation and fibrinolysis of post-SARS osteonecrosis in a Chinese population. / Int Orthop. 2006;30:143-46. CrossRef
  72. Szepesi K, Posan E, Harsfalvi J, Ajzner E, Szucs G, Gaspar L, Csernatony Z, Udvardy M. The most severe forms of Perthes-disease associated with the homozygous Factor V Leiden mutation. / J Bone Joint Surg Br. 2004;86:426-29. CrossRef
  73. Tao SN. Hemodynamics changes in proximal femur of patients with femoral head necrosis [in Chinese]. / Zhonghua Wai Ke Za Zhi. 1991;29:452-54, 464.
  74. Tosetto A, Castaman G, Cappellari A, Rodeghiero F. The VITA Project: heritability of resistance to activated protein C. Vincenza Thrombophilia and Arteriosclerosis. / Thromb Haemost. 2000;84:811-14.
  75. Tripodi A. Issues concerning the laboratory investigation of inherited thrombophilia. / Mol Diagn. 2005;9:181-86. CrossRef
  76. Van Veldhuizen PJ, Neff J, Murphey MD, Bodensteiner D, Skikne BS. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip. / Am J Hematol. 1993;44:243-48. jh.2830440405">CrossRef
  77. Wahlander K, Larson G, Lindahl TL, Andersson C, Frison L, Gustafsson D, Bylock A, Eriksson BI. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery. / Thromb Haemost. 2002;87:580-85.
  78. Westrich GH, Weksler BB, Glueck CJ, Blumenthal BF, Salvati EA. Correlation of thrombophilia and hypofibrinolysis with pulmonary embolism following total hip arthroplasty: an analysis of genetic factors. / J Bone Joint Surg Am. 2002;84:2161-167.
  79. Zalavras C, Dailiana Z, Elisaf M, Bairaktari E, Vlachogiannopoulos P, Katsaraki A, Malizos KN. Potential aetiological factors concerning the development of osteonecrosis of the femoral head. / Eur J Clin Invest. 2000;30:215-21. j.1365-2362.2000.00621.x">CrossRef
  80. Zalavras CG, Vartholomatos G, Dokou E, Malizos KN. Genetic background of osteonecrosis: associated with thrombophilic mutations? / Clin Orthop Relat Res. 2004;422:251-55. CrossRef
  
• 作者单位：Charles J. Glueck MD (1)
  Richard A. Freiberg MD (2)
  Ping Wang PhD (1)
  
  1. Cholesterol Center, Jewish Hospital, ABC Building, 3200 Burnet Avenue, Cincinnati, OH, 45229, USA
  2. Cincinnati Veteran’s Administration Hospital, Cincinnati, OH, USA
  

文摘

We hypothesized that inherited thrombophilia and hypofibrinolysis were risk factors for osteonecrosis of the femoral head. We compared measures of thrombophilia and hypofibrinolysis in referred new adult patients with idiopathic osteonecrosis (n?=?71) or secondary osteonecrosis (n?=?62) with the same measures in sex- and race-matched healthy control subjects. Heritable thrombophilic Factor VIII and hypofibrinolytic Lp(a) were more frequently high in the 71 patients with idiopathic osteonecrosis than in control subjects. High Factor VIII, Factor V Leiden heterozygosity, and resistance to activated protein C, all heritable thrombophilias, were more frequently present in the 62 patients with secondary osteonecrosis than in control subjects. Our data suggest inherited thrombophilia and hypofibrinolysis are risk factors for both idiopathic and secondary osteonecrosis of the head of the femur. Level of Evidence: Level IV, prognostic study. See the Guidelines for Authors for a complete description of levels of evidence.